India Pesticides Limited Posts 30% Revenue Rise, 41% Profit Jump in Q3 FY26

In the December 2025 quarter, IPL posted revenue of Rs 229 crore, a 30.7% YoY increase, and net profit of Rs 23 crore, up 41.2%, while EBITDA rose 39.7% to Rs 41 crore. Growth was driven by higher domestic herbicide sales, expanding exports and a new 6 MW solar plant supporting cost efficiency.

Zota Healthcare Converts All Warrants into Shares, Raises Rs 21.8 crore

Zota Healthcare exercised 571,961 warrants at Rs 509 per share, receiving Rs 21.83 crore and raising paid‑up capital to Rs 34.63 crore, while diluting shareholders by roughly 1.66% and eliminating all outstanding warrants.

PAR Drugs and Chemicals posts 730% Q3 profit surge as revenue jumps 37%

The board approved unaudited results for Q3 2025 and the first nine months of FY 2025‑26, showing a 37% rise in quarterly revenue to ₹2.93 billion and a 730% jump in profit after tax to ₹479.7 million. Nine‑month earnings grew modestly, and governance updates resolved all investor complaints.

India Glycols posts higher Q4 sales, profit and raises capital ahead of demerger

The company reported Q4 revenue of ₹2.55 billion and profit after tax of ₹65.3 million, with earnings per share rising to ₹10.42, while a ₹4.67 billion equity raise boosted paid‑up capital to ₹33.5 billion. It also secured NCLT approval to split its Spirits and Bio‑Fuel businesses into a listed entity.

Dev Information Technology posts Q3 loss, buys stake, extends redemption

The company reported an operating loss of about ₹‑730 lakh for the quarter ended 31 Dec 2025, offset by a one‑time associate gain. It also bought a 19 % stake in Scaleax Advisory and pushed the redemption date of 3.58 million preference shares to March 2031.